Oral glucose tolerance, plasma insulin, and uric acid excretion in man during chronic administration of nicotinic acid.
D000410:Alanine Transaminase / Q000097:blood; D001219:Aspartate Aminotransferases / Q000097:blood; D001786:Blood Glucose / Q000032:analysis; D001796:Blood Protein Disorders / Q000188:drug therapy; D002784:Cholesterol / Q000097:blood; D005947:Glucose / Q000378:metabolism*; D005951:Glucose Tolerance Test; D006029:Glycosuria; D006801:Humans; D000960:Hypolipidemic Agents / Q000494:pharmacology* / Q000627:therapeutic use; D007328:Insulin / Q000097:blood*; D007657:Ketone Bodies / Q000652:urine; D007668:Kidney / Q000502:physiology; D008074:Lipoproteins / Q000097:blood; D009539:Nicotinic Acids / Q000494:pharmacology* / Q000627:therapeutic use; D014280:Triglycerides / Q000097:blood; D014527:Uric Acid / Q000032:analysis*
D001786:Blood Glucose; D000960:Hypolipidemic Agents; D007328:Insulin; D007657:Ketone Bodies; D008074:Lipoproteins; D009539:Nicotinic Acids; D014280:Triglycerides; D014527:Uric Acid; D002784:Cholesterol; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; D005947:Glucose